nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP1A1—Dacarbazine—muscle cancer	0.279	0.34	CbGbCtD
Dexmedetomidine—CYP2E1—Dacarbazine—muscle cancer	0.216	0.263	CbGbCtD
Dexmedetomidine—CYP1A2—Dacarbazine—muscle cancer	0.125	0.152	CbGbCtD
Dexmedetomidine—CYP2E1—Etoposide—muscle cancer	0.106	0.129	CbGbCtD
Dexmedetomidine—CYP1A2—Etoposide—muscle cancer	0.0611	0.0744	CbGbCtD
Dexmedetomidine—CYP2D6—Doxorubicin—muscle cancer	0.0343	0.0418	CbGbCtD
Dexmedetomidine—Septic shock—Vincristine—muscle cancer	0.00685	0.0382	CcSEcCtD
Dexmedetomidine—Septic shock—Etoposide—muscle cancer	0.00555	0.031	CcSEcCtD
Dexmedetomidine—Metabolic acidosis—Etoposide—muscle cancer	0.00424	0.0237	CcSEcCtD
Dexmedetomidine—Nephropathy—Etoposide—muscle cancer	0.00352	0.0196	CcSEcCtD
Dexmedetomidine—Septic shock—Doxorubicin—muscle cancer	0.00288	0.0161	CcSEcCtD
Dexmedetomidine—Neuritis—Vincristine—muscle cancer	0.00277	0.0155	CcSEcCtD
Dexmedetomidine—Hypocalcaemia—Dactinomycin—muscle cancer	0.00253	0.0141	CcSEcCtD
Dexmedetomidine—Sinus tachycardia—Doxorubicin—muscle cancer	0.00216	0.012	CcSEcCtD
Dexmedetomidine—Nephropathy—Methotrexate—muscle cancer	0.00211	0.0118	CcSEcCtD
Dexmedetomidine—Respiratory failure—Vincristine—muscle cancer	0.00211	0.0118	CcSEcCtD
Dexmedetomidine—Rigors—Etoposide—muscle cancer	0.00205	0.0115	CcSEcCtD
Dexmedetomidine—Sepsis—Dactinomycin—muscle cancer	0.00201	0.0112	CcSEcCtD
Dexmedetomidine—Apnoea—Etoposide—muscle cancer	0.00198	0.011	CcSEcCtD
Dexmedetomidine—Cardiovascular disorder—Etoposide—muscle cancer	0.00191	0.0106	CcSEcCtD
Dexmedetomidine—Pneumothorax—Doxorubicin—muscle cancer	0.00175	0.00975	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Etoposide—muscle cancer	0.00168	0.00935	CcSEcCtD
Dexmedetomidine—Hypernatraemia—Doxorubicin—muscle cancer	0.00165	0.00923	CcSEcCtD
Dexmedetomidine—Hypoxia—Methotrexate—muscle cancer	0.00158	0.00882	CcSEcCtD
Dexmedetomidine—Hypothermia—Doxorubicin—muscle cancer	0.00155	0.00865	CcSEcCtD
Dexmedetomidine—Body temperature decreased—Doxorubicin—muscle cancer	0.00155	0.00865	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.00151	0.00845	CcSEcCtD
Dexmedetomidine—Hypophosphataemia—Doxorubicin—muscle cancer	0.0015	0.00835	CcSEcCtD
Dexmedetomidine—Generalised oedema—Doxorubicin—muscle cancer	0.00146	0.00816	CcSEcCtD
Dexmedetomidine—Sepsis—Etoposide—muscle cancer	0.00145	0.00812	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Vincristine—muscle cancer	0.00143	0.00797	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Etoposide—muscle cancer	0.0014	0.00781	CcSEcCtD
Dexmedetomidine—Hypomagnesaemia—Doxorubicin—muscle cancer	0.00137	0.00764	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.00135	0.00755	CcSEcCtD
Dexmedetomidine—Pleural effusion—Methotrexate—muscle cancer	0.00131	0.00732	CcSEcCtD
Dexmedetomidine—Pneumonia—Dactinomycin—muscle cancer	0.0013	0.00727	CcSEcCtD
Dexmedetomidine—Neuralgia—Doxorubicin—muscle cancer	0.00125	0.00698	CcSEcCtD
Dexmedetomidine—Apnoea—Methotrexate—muscle cancer	0.00118	0.00661	CcSEcCtD
Dexmedetomidine—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.00117	0.00655	CcSEcCtD
Dexmedetomidine—Speech disorder—Methotrexate—muscle cancer	0.00117	0.00651	CcSEcCtD
Dexmedetomidine—Neuritis—Doxorubicin—muscle cancer	0.00116	0.0065	CcSEcCtD
Dexmedetomidine—Pneumonia—Vincristine—muscle cancer	0.00116	0.0065	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Etoposide—muscle cancer	0.00116	0.00646	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Vincristine—muscle cancer	0.00114	0.00637	CcSEcCtD
Dexmedetomidine—Pleural effusion—Doxorubicin—muscle cancer	0.00114	0.00633	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Vincristine—muscle cancer	0.00113	0.00633	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Vincristine—muscle cancer	0.00113	0.00633	CcSEcCtD
Dexmedetomidine—Hyperbilirubinaemia—Methotrexate—muscle cancer	0.0011	0.00616	CcSEcCtD
Dexmedetomidine—Oliguria—Methotrexate—muscle cancer	0.00109	0.00608	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00107	0.00599	CcSEcCtD
Dexmedetomidine—Rigors—Doxorubicin—muscle cancer	0.00106	0.00594	CcSEcCtD
Dexmedetomidine—Chills—Dactinomycin—muscle cancer	0.00104	0.00582	CcSEcCtD
Dexmedetomidine—Bronchospasm—Etoposide—muscle cancer	0.00103	0.00577	CcSEcCtD
Dexmedetomidine—Hallucination—Vincristine—muscle cancer	0.00103	0.00577	CcSEcCtD
Dexmedetomidine—Sweating increased—Etoposide—muscle cancer	0.00102	0.00572	CcSEcCtD
Dexmedetomidine—Respiratory failure—Methotrexate—muscle cancer	0.00102	0.0057	CcSEcCtD
Dexmedetomidine—Delirium—Doxorubicin—muscle cancer	0.00101	0.00564	CcSEcCtD
Dexmedetomidine—Cardiovascular disorder—Doxorubicin—muscle cancer	0.000989	0.00552	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Vincristine—muscle cancer	0.000964	0.00538	CcSEcCtD
Dexmedetomidine—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.000956	0.00533	CcSEcCtD
Dexmedetomidine—Hypocalcaemia—Doxorubicin—muscle cancer	0.00095	0.0053	CcSEcCtD
Dexmedetomidine—Oliguria—Doxorubicin—muscle cancer	0.000943	0.00526	CcSEcCtD
Dexmedetomidine—Pneumonia—Etoposide—muscle cancer	0.000943	0.00526	CcSEcCtD
Dexmedetomidine—Angiopathy—Vincristine—muscle cancer	0.000943	0.00526	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Vincristine—muscle cancer	0.000937	0.00523	CcSEcCtD
Dexmedetomidine—Anaemia—Dactinomycin—muscle cancer	0.000936	0.00522	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Etoposide—muscle cancer	0.000924	0.00516	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Etoposide—muscle cancer	0.000919	0.00513	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Etoposide—muscle cancer	0.000919	0.00513	CcSEcCtD
Dexmedetomidine—Mental disorder—Vincristine—muscle cancer	0.00091	0.00508	CcSEcCtD
Dexmedetomidine—Atrioventricular block—Doxorubicin—muscle cancer	0.000896	0.005	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Methotrexate—muscle cancer	0.000894	0.00499	CcSEcCtD
Dexmedetomidine—Sepsis—Methotrexate—muscle cancer	0.000871	0.00486	CcSEcCtD
Dexmedetomidine—Ventricular tachycardia—Doxorubicin—muscle cancer	0.000869	0.00485	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.000869	0.00485	CcSEcCtD
Dexmedetomidine—Hyperkalaemia—Doxorubicin—muscle cancer	0.000854	0.00477	CcSEcCtD
Dexmedetomidine—Anaemia—Vincristine—muscle cancer	0.000836	0.00466	CcSEcCtD
Dexmedetomidine—Agitation—Vincristine—muscle cancer	0.000831	0.00464	CcSEcCtD
Dexmedetomidine—Fluid retention—Doxorubicin—muscle cancer	0.000825	0.00461	CcSEcCtD
Dexmedetomidine—Infection—Dactinomycin—muscle cancer	0.000821	0.00458	CcSEcCtD
Dexmedetomidine—Blood urea increased—Doxorubicin—muscle cancer	0.000821	0.00458	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Dactinomycin—muscle cancer	0.000809	0.00451	CcSEcCtD
Dexmedetomidine—Renal failure acute—Methotrexate—muscle cancer	0.000789	0.0044	CcSEcCtD
Dexmedetomidine—Convulsion—Vincristine—muscle cancer	0.000784	0.00437	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Etoposide—muscle cancer	0.000781	0.00436	CcSEcCtD
Dexmedetomidine—Hypertension—Vincristine—muscle cancer	0.000781	0.00436	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Doxorubicin—muscle cancer	0.000774	0.00432	CcSEcCtD
Dexmedetomidine—Angiopathy—Etoposide—muscle cancer	0.000764	0.00426	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Etoposide—muscle cancer	0.000759	0.00423	CcSEcCtD
Dexmedetomidine—Abnormal vision—Doxorubicin—muscle cancer	0.000758	0.00423	CcSEcCtD
Dexmedetomidine—Chills—Etoposide—muscle cancer	0.000755	0.00421	CcSEcCtD
Dexmedetomidine—Sepsis—Doxorubicin—muscle cancer	0.000754	0.00421	CcSEcCtD
Dexmedetomidine—Infection—Vincristine—muscle cancer	0.000733	0.00409	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.000726	0.00405	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Vincristine—muscle cancer	0.000723	0.00403	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000722	0.00403	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Vincristine—muscle cancer	0.000714	0.00398	CcSEcCtD
Dexmedetomidine—Pain—Dactinomycin—muscle cancer	0.000707	0.00394	CcSEcCtD
Dexmedetomidine—Hypotension—Vincristine—muscle cancer	0.00069	0.00385	CcSEcCtD
Dexmedetomidine—Renal failure acute—Doxorubicin—muscle cancer	0.000684	0.00381	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Dactinomycin—muscle cancer	0.000681	0.0038	CcSEcCtD
Dexmedetomidine—Anaemia—Etoposide—muscle cancer	0.000677	0.00378	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000676	0.00377	CcSEcCtD
Dexmedetomidine—Abdominal pain—Dactinomycin—muscle cancer	0.000653	0.00364	CcSEcCtD
Dexmedetomidine—Body temperature increased—Dactinomycin—muscle cancer	0.000653	0.00364	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Doxorubicin—muscle cancer	0.000647	0.00361	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000637	0.00356	CcSEcCtD
Dexmedetomidine—Convulsion—Etoposide—muscle cancer	0.000635	0.00354	CcSEcCtD
Dexmedetomidine—Hypertension—Etoposide—muscle cancer	0.000633	0.00353	CcSEcCtD
Dexmedetomidine—Pain—Vincristine—muscle cancer	0.000631	0.00352	CcSEcCtD
Dexmedetomidine—Constipation—Vincristine—muscle cancer	0.000631	0.00352	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Vincristine—muscle cancer	0.000604	0.00337	CcSEcCtD
Dexmedetomidine—Confusional state—Etoposide—muscle cancer	0.000603	0.00336	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Doxorubicin—muscle cancer	0.0006	0.00335	CcSEcCtD
Dexmedetomidine—Infection—Etoposide—muscle cancer	0.000594	0.00331	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Etoposide—muscle cancer	0.000586	0.00327	CcSEcCtD
Dexmedetomidine—Tachycardia—Etoposide—muscle cancer	0.000584	0.00326	CcSEcCtD
Dexmedetomidine—Abdominal pain—Vincristine—muscle cancer	0.000584	0.00326	CcSEcCtD
Dexmedetomidine—Body temperature increased—Vincristine—muscle cancer	0.000584	0.00326	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Etoposide—muscle cancer	0.000578	0.00323	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Doxorubicin—muscle cancer	0.000574	0.0032	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000568	0.00317	CcSEcCtD
Dexmedetomidine—Diarrhoea—Dactinomycin—muscle cancer	0.000565	0.00315	CcSEcCtD
Dexmedetomidine—Pneumonia—Methotrexate—muscle cancer	0.000565	0.00315	CcSEcCtD
Dexmedetomidine—Hypotension—Etoposide—muscle cancer	0.000559	0.00312	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000557	0.00311	CcSEcCtD
Dexmedetomidine—Abdominal distension—Doxorubicin—muscle cancer	0.000549	0.00306	CcSEcCtD
Dexmedetomidine—Dyspnoea—Etoposide—muscle cancer	0.000533	0.00297	CcSEcCtD
Dexmedetomidine—Somnolence—Etoposide—muscle cancer	0.000532	0.00297	CcSEcCtD
Dexmedetomidine—Vomiting—Dactinomycin—muscle cancer	0.000525	0.00293	CcSEcCtD
Dexmedetomidine—Rash—Dactinomycin—muscle cancer	0.000521	0.00291	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000516	0.00288	CcSEcCtD
Dexmedetomidine—Pain—Etoposide—muscle cancer	0.000511	0.00285	CcSEcCtD
Dexmedetomidine—Constipation—Etoposide—muscle cancer	0.000511	0.00285	CcSEcCtD
Dexmedetomidine—Haemoglobin—Methotrexate—muscle cancer	0.000507	0.00283	CcSEcCtD
Dexmedetomidine—Diarrhoea—Vincristine—muscle cancer	0.000505	0.00282	CcSEcCtD
Dexmedetomidine—Haemorrhage—Methotrexate—muscle cancer	0.000504	0.00281	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Etoposide—muscle cancer	0.000493	0.00275	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000492	0.00275	CcSEcCtD
Dexmedetomidine—Nausea—Dactinomycin—muscle cancer	0.000491	0.00274	CcSEcCtD
Dexmedetomidine—Pneumonia—Doxorubicin—muscle cancer	0.000489	0.00273	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Etoposide—muscle cancer	0.000489	0.00273	CcSEcCtD
Dexmedetomidine—Dizziness—Vincristine—muscle cancer	0.000488	0.00272	CcSEcCtD
Dexmedetomidine—Visual impairment—Methotrexate—muscle cancer	0.000486	0.00271	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000477	0.00266	CcSEcCtD
Dexmedetomidine—Abdominal pain—Etoposide—muscle cancer	0.000473	0.00264	CcSEcCtD
Dexmedetomidine—Body temperature increased—Etoposide—muscle cancer	0.000473	0.00264	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Doxorubicin—muscle cancer	0.000473	0.00264	CcSEcCtD
Dexmedetomidine—Vomiting—Vincristine—muscle cancer	0.000469	0.00262	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Methotrexate—muscle cancer	0.000468	0.00261	CcSEcCtD
Dexmedetomidine—Rash—Vincristine—muscle cancer	0.000465	0.0026	CcSEcCtD
Dexmedetomidine—Dermatitis—Vincristine—muscle cancer	0.000465	0.00259	CcSEcCtD
Dexmedetomidine—Headache—Vincristine—muscle cancer	0.000463	0.00258	CcSEcCtD
Dexmedetomidine—Angiopathy—Methotrexate—muscle cancer	0.000457	0.00255	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Methotrexate—muscle cancer	0.000454	0.00254	CcSEcCtD
Dexmedetomidine—Chills—Methotrexate—muscle cancer	0.000452	0.00252	CcSEcCtD
Dexmedetomidine—Bradycardia—Doxorubicin—muscle cancer	0.000444	0.00248	CcSEcCtD
Dexmedetomidine—Mental disorder—Methotrexate—muscle cancer	0.000442	0.00246	CcSEcCtD
Dexmedetomidine—Malnutrition—Methotrexate—muscle cancer	0.000439	0.00245	CcSEcCtD
Dexmedetomidine—Haemoglobin—Doxorubicin—muscle cancer	0.000439	0.00245	CcSEcCtD
Dexmedetomidine—Nausea—Vincristine—muscle cancer	0.000439	0.00245	CcSEcCtD
Dexmedetomidine—Haemorrhage—Doxorubicin—muscle cancer	0.000437	0.00244	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Doxorubicin—muscle cancer	0.00043	0.0024	CcSEcCtD
Dexmedetomidine—Visual impairment—Doxorubicin—muscle cancer	0.000421	0.00235	CcSEcCtD
Dexmedetomidine—Diarrhoea—Etoposide—muscle cancer	0.000409	0.00228	CcSEcCtD
Dexmedetomidine—Anaemia—Methotrexate—muscle cancer	0.000406	0.00226	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Doxorubicin—muscle cancer	0.000405	0.00226	CcSEcCtD
Dexmedetomidine—Angiopathy—Doxorubicin—muscle cancer	0.000396	0.00221	CcSEcCtD
Dexmedetomidine—Dizziness—Etoposide—muscle cancer	0.000395	0.00221	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000393	0.0022	CcSEcCtD
Dexmedetomidine—Chills—Doxorubicin—muscle cancer	0.000392	0.00219	CcSEcCtD
Dexmedetomidine—Arrhythmia—Doxorubicin—muscle cancer	0.00039	0.00218	CcSEcCtD
Dexmedetomidine—Mental disorder—Doxorubicin—muscle cancer	0.000383	0.00213	CcSEcCtD
Dexmedetomidine—Convulsion—Methotrexate—muscle cancer	0.00038	0.00212	CcSEcCtD
Dexmedetomidine—Vomiting—Etoposide—muscle cancer	0.00038	0.00212	CcSEcCtD
Dexmedetomidine—Malnutrition—Doxorubicin—muscle cancer	0.00038	0.00212	CcSEcCtD
Dexmedetomidine—Rash—Etoposide—muscle cancer	0.000377	0.0021	CcSEcCtD
Dexmedetomidine—Dermatitis—Etoposide—muscle cancer	0.000377	0.0021	CcSEcCtD
Dexmedetomidine—Headache—Etoposide—muscle cancer	0.000375	0.00209	CcSEcCtD
Dexmedetomidine—Confusional state—Methotrexate—muscle cancer	0.000361	0.00202	CcSEcCtD
Dexmedetomidine—Infection—Methotrexate—muscle cancer	0.000356	0.00199	CcSEcCtD
Dexmedetomidine—Nausea—Etoposide—muscle cancer	0.000355	0.00198	CcSEcCtD
Dexmedetomidine—Anaemia—Doxorubicin—muscle cancer	0.000351	0.00196	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Methotrexate—muscle cancer	0.000351	0.00196	CcSEcCtD
Dexmedetomidine—Agitation—Doxorubicin—muscle cancer	0.000349	0.00195	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Methotrexate—muscle cancer	0.000346	0.00193	CcSEcCtD
Dexmedetomidine—Hypotension—Methotrexate—muscle cancer	0.000335	0.00187	CcSEcCtD
Dexmedetomidine—Convulsion—Doxorubicin—muscle cancer	0.000329	0.00184	CcSEcCtD
Dexmedetomidine—Hypertension—Doxorubicin—muscle cancer	0.000328	0.00183	CcSEcCtD
Dexmedetomidine—Anxiety—Doxorubicin—muscle cancer	0.000322	0.0018	CcSEcCtD
Dexmedetomidine—Dyspnoea—Methotrexate—muscle cancer	0.000319	0.00178	CcSEcCtD
Dexmedetomidine—Somnolence—Methotrexate—muscle cancer	0.000318	0.00178	CcSEcCtD
Dexmedetomidine—Dry mouth—Doxorubicin—muscle cancer	0.000316	0.00177	CcSEcCtD
Dexmedetomidine—Confusional state—Doxorubicin—muscle cancer	0.000313	0.00174	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000309	0.00173	CcSEcCtD
Dexmedetomidine—Infection—Doxorubicin—muscle cancer	0.000308	0.00172	CcSEcCtD
Dexmedetomidine—Pain—Methotrexate—muscle cancer	0.000306	0.00171	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000304	0.00169	CcSEcCtD
Dexmedetomidine—Tachycardia—Doxorubicin—muscle cancer	0.000303	0.00169	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Doxorubicin—muscle cancer	0.0003	0.00167	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Methotrexate—muscle cancer	0.000295	0.00165	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000293	0.00163	CcSEcCtD
Dexmedetomidine—Hypotension—Doxorubicin—muscle cancer	0.00029	0.00162	CcSEcCtD
Dexmedetomidine—Abdominal pain—Methotrexate—muscle cancer	0.000283	0.00158	CcSEcCtD
Dexmedetomidine—Body temperature increased—Methotrexate—muscle cancer	0.000283	0.00158	CcSEcCtD
Dexmedetomidine—Dyspnoea—Doxorubicin—muscle cancer	0.000277	0.00154	CcSEcCtD
Dexmedetomidine—Somnolence—Doxorubicin—muscle cancer	0.000276	0.00154	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000268	0.00149	CcSEcCtD
Dexmedetomidine—Constipation—Doxorubicin—muscle cancer	0.000265	0.00148	CcSEcCtD
Dexmedetomidine—Pain—Doxorubicin—muscle cancer	0.000265	0.00148	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Doxorubicin—muscle cancer	0.000256	0.00143	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000254	0.00142	CcSEcCtD
Dexmedetomidine—Abdominal pain—Doxorubicin—muscle cancer	0.000245	0.00137	CcSEcCtD
Dexmedetomidine—Body temperature increased—Doxorubicin—muscle cancer	0.000245	0.00137	CcSEcCtD
Dexmedetomidine—Diarrhoea—Methotrexate—muscle cancer	0.000245	0.00137	CcSEcCtD
Dexmedetomidine—Dizziness—Methotrexate—muscle cancer	0.000237	0.00132	CcSEcCtD
Dexmedetomidine—Vomiting—Methotrexate—muscle cancer	0.000228	0.00127	CcSEcCtD
Dexmedetomidine—Rash—Methotrexate—muscle cancer	0.000226	0.00126	CcSEcCtD
Dexmedetomidine—Dermatitis—Methotrexate—muscle cancer	0.000226	0.00126	CcSEcCtD
Dexmedetomidine—Headache—Methotrexate—muscle cancer	0.000224	0.00125	CcSEcCtD
Dexmedetomidine—Nausea—Methotrexate—muscle cancer	0.000213	0.00119	CcSEcCtD
Dexmedetomidine—Diarrhoea—Doxorubicin—muscle cancer	0.000212	0.00118	CcSEcCtD
Dexmedetomidine—Dizziness—Doxorubicin—muscle cancer	0.000205	0.00114	CcSEcCtD
Dexmedetomidine—Vomiting—Doxorubicin—muscle cancer	0.000197	0.0011	CcSEcCtD
Dexmedetomidine—Rash—Doxorubicin—muscle cancer	0.000196	0.00109	CcSEcCtD
Dexmedetomidine—Dermatitis—Doxorubicin—muscle cancer	0.000195	0.00109	CcSEcCtD
Dexmedetomidine—Headache—Doxorubicin—muscle cancer	0.000194	0.00108	CcSEcCtD
Dexmedetomidine—Nausea—Doxorubicin—muscle cancer	0.000184	0.00103	CcSEcCtD
